Sfoglia per Autore
Master protocols in immuno-oncology : Do novel drugs deserve novel designs?
2020 L. Mazzarella, S. Morganti, A. Marra, D. Trapani, G. Tini, P. Pelicci, G. Curigliano
TMBleR, a bioinformatic tool to optimize TMB estimation and predictive power
2021 L. Fancello, A. Guida, G. Frige, A.G. Michel Ceol, G. Babini, G.L. Scaglione, M. Zanfardino, T. Mazza, L. Ferrando, P.G. Pelicci, L. Mazzarella
The evolving paradigm of biomarker actionability: Histology-agnosticism as a spectrum, rather than a binary quality
2021 P. Tarantino, L. Mazzarella, A. Marra, D. Trapani, G. Curigliano
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis
2021 A. Esposito, A. Marra, V. Bagnardi, S. Frassoni, S. Morganti, G. Viale, P. Zagami, G.M. Varano, G. Buccimazza, F. Orsi, K. Venetis, L. Mazzarella, G. Viale, N. Fusco, C. Criscitiello, G. Curigliano
Machine learning-based reclassification of germline variants of unknown significance: The RENOVO algorithm
2021 V. Favalli, G. Tini, E. Bonetti, G. Vozza, A. Guida, S. Gandini, P.G. Pelicci, L. Mazzarella
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
2021 E. de Guillebon, M. Jimenez, L. Mazzarella, F. Betsou, P. Stadler, I. Peták, E. Jeannot, L. Chanas, N. Servant, G. Marret, B.A. Duso, F. Legrand, K.N. Kornerup, S.H. Bernhart, G. Balogh, R. Dóczi, P. Filotás, G. Curigliano, I. Bièche, J. Guérin, A. Dirner, C. Neuzillet, N. Girard, E. Borcoman, L. Larbi Chérif, P. Tresca, D.B. Roufai, C. Dupain, S. Scholl, F. André, X. Fernandez, T. Filleron, M. Kamal, C. Le Tourneau
The Challenge of Choosing the Best Classification Method in Radiomic Analyses: Recommendations and Applications to Lung Cancer CT Images
2021 F. Corso, G. Tini, G. Lo Presti, N. Garau, S.P. De Angelis, F. Bellerba, L. Rinaldi, F. Botta, S. Rizzo, D. Origgi, C. Paganelli, M. Cremonesi, C. Rampinelli, M. Bellomi, L. Mazzarella, P.G. Pelicci, S. Gandini, S. Raimondi
Prospective validation of the Italian alliance against cancer lung panel in patients with advanced non–small-cell lung cancer
2021 V. Gregorc, L. Mazzarella, C. Lazzari, P. Graziano, P. Vigneri, C. Genova, L. Toschi, G. Ciliberto, L. Bonanno, A. Delmonte, G. Bucci, A. Rossi, G. Motta, S. Coco, A. Marinello, S. Buglioni, M.G. Cangi, C. Di Micco, A. Bandiera, S. Bonfiglio, L. Pecciarini, A. Guida, A. Ceol, G. Frige', R. De Maria, P.G. Pelicci
Detection of clustered circulating tumour cells in early breast cancer
2021 I. Krol, F.D. Schwab, R. Carbone, M. Ritter, S. Picocci, M.L. De Marni, G. Stepien, G.M. Franchi, A. Zanardi, M.D. Rissoglio, A. Covelli, G. Guidi, D. Scarinci, F. Castro-Giner, L. Mazzarella, C. Doglioni, F. Borghi, P. Milani, C. Kurzeder, W.P. Weber, N. Aceto
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population
2022 L. Mazzarella, F. Giugliano, E. Nicolo', E. Crimini, J. Uliano, C. Corti, P. D'Amico, P. Aliaga, C. Valenza, M. Repetto, G. Antonarelli, L. Ascione, G. Vivanet, P. Giachetti, I. Minchella, C. Belli, A. Esposito, M. Locatelli, C. Criscitiello, G. Curigliano
The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population
2022 L. Mazzarella, E. Nicolò, A. Esposito, E. Crimini, G. Tini, J. Uliano, C. Corti, P. Trillo Aliaga, C. Valenza, M. Repetto, G. Antonarelli, I. Minchella, C. Belli, M. Locatelli, C. Criscitiello, G. Curigliano
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses
2023 L. Mazzarella, F. Santoro, R. Ravasio, V. Fumagalli, P.E. Massa, S. Rodighiero, E. Gavilán, M. Romanenghi, B.A. Duso, E. Bonetti, L. Manganaro, R. Pallavi, D. Trastulli, I. Pallavicini, C. Gentile, S. Monzani, T. Leonardi, S. Pasqualato, G. Buttinelli, A. Di Martino, G. Fedele, I. Schiavoni, P. Stefanelli, G. Meroni, R. de Francesco, C. Steinkuhler, G. Fossati, M. Iannacone, S. Minucci, P.G. Pelicci
High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias
2023 A. Magi, G. Mattei, A. Mingrino, C. Caprioli, C. Ronchini, G. Frigè, R. Semeraro, D. Bolognini, A. Rambaldi, A. Candoni, E. Colombo, L. Mazzarella, P.G. Pelicci
Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer
2024 P. Di Chiaro, L. Nacci, F. Arco, S. Brandini, S. Polletti, A. Palamidessi, B. Donati, C. Soriani, F. Gualdrini, G. Frigè, L. Mazzarella, A. Ciarrocchi, A. Zerbi, P. Spaggiari, G. Scita, S. Rodighiero, I. Barozzi, G.R. Diaferia, G. Natoli
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile